EUVIMEDEUVIMED entdecken
Crossref

Downregulation of ATP5F1D inhibits mtROS/NLRP3/caspase-1/GSDMD axis to suppress pyroptosis-mediated malignant progression of endometrial cancer

Yuemei Cheng, Xi Chen, Dan Hu, Junhong Du, Yijuan Xing, Xiaolei Liang, Yongxiu Yang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yuemei Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gyne…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Mice, Nude. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: In developed countries, endometrial cancer (EC) is the most prevalent gynecological cancer and its occurrence is associated with chronic inflammation. ATP5F1D is a subunit of ATP synthase (complex V), as well as the important component of mitochondrial electron transport chain (ETC). ETC play compelling roles in carcinogenesis. To date, little is known about the role of ATP5F1D in EC. METHODS: ATP5F1D expression was identified in EC tissues and EC cell lines. We evaluated the influence of ATP5F1D on clinical features and prognosis based on TCGA database. The effects of ATP5F1D in EC malignant progression by applying loss-of-function assays in KLE and Ishikawa cell lines were detected by EdU, CCK-8, wound healing, Transwell, and flow cytometry assays. Additionally, electron microscope, LDH release, ELISA, mitochondrial ROS measurement, and Immunofluorescence were performed to demonstrate ATP5F1D can affect the pyroptosis of EC. To observe the anti-tumor effect on ATP5F1D silencing, we established an in vivo human endometrial tumor model using nude mice. RESULTS: ATP5F1D expression was significantly upregulated in EC and was associated with favorable prognosis. ATP5F1D knockdown inhibited the proliferation, invasion, and migration of EC cells. Similarly, in nude mice, ATP5F1D knockdown suppressed the growth EC cells. Knocking down ATP5F1D lead to decrease the production of mitochondrial ROS (mtROS) and inhibited pyroptosis of EC cells. CONCLUSION: Downregulation of ATP5F1D as a new therapeutic strategy that could mediate pyroptosis via suppressing mtROS/NLRP3/caspase-1/GSDMD pathway to inhibit EC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisMice, NudeCaspase 1Mitochondrial Proton-Translocating ATPasesHumansFemaleAnimalsCell Line, TumorMiceDown-RegulationDisease ProgressionMice, Inbred BALB CMitochondriaSignal TransductionReactive Oxygen SpeciesGene Expression Regulation, NeoplasticGasderminsPhosphate-Binding Proteins

Stichwörter der Autor:innen

ATP5F1DEndometrial cancerMitochondrial ROSNLRP3Pyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Mitochondrial Proton-Translocating ATPasesGSDMD protein, humanNLRP3 protein, humanReactive Oxygen SpeciesGasderminsPhosphate-Binding Proteins

Autor:innen und Institutionen

  • The First Clinical Medical College of Lanzhou University, Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou 730000, Gansu, China; Department of Obstet…
  • The First Clinical Medical College of Lanzhou University, Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou 730000, Gansu, China.
  • Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou 730000, Gansu, China.
  • Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou 730000, Gansu, China. Electronic address: yxyanglzu@163.co…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cheng, Y., Chen, X., Hu, D., Du, J., Xing, Y., Liang, X., & Yang, Y. (2024). Downregulation of ATP5F1D inhibits mtROS/NLRP3/caspase-1/GSDMD axis to suppress pyroptosis-mediated malignant progression of endometrial cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112808

Vancouver

Cheng Y, Chen X, Hu D, Du J, Xing Y, Liang X, et al. Downregulation of ATP5F1D inhibits mtROS/NLRP3/caspase-1/GSDMD axis to suppress pyroptosis-mediated malignant progression of endometrial cancer. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112808

BibTeX
@article{Cheng2024,
  author = {Cheng, Yuemei and Chen, Xi and Hu, Dan and Du, Junhong and Xing, Yijuan and Liang, Xiaolei and Yang, Yongxiu},
  title = {Downregulation of ATP5F1D inhibits mtROS/NLRP3/caspase-1/GSDMD axis to suppress pyroptosis-mediated malignant progression of endometrial cancer},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112808}
}
Kostenlos starten →